Description
Oseni (alogliptin and pioglitazone) is a drug that is used with diet and exercise to treat type 2 diabetes in adults.
Fact Table |
Formula |
C18H21N5O2, C19H20N2O3S |
License |
US DailyMed, US FDA, EU EMA |
Bioavailability |
100% |
Legal status |
Rx-Only |
Chemical Name |
Alogliptin/pioglitazone |
Elimination half-life |
3–21 hours |
Dosage (Strength) |
12.5mg/45mg, 12.5mg/15mg, 25mg/15mg, 12.5mg/30 mg, 25mg/30mg, 25mg/45mg |
Pregnancy |
Consult Doctor |
Brands |
Oseni |
Protein binding |
20% |
PubChem CID |
11450633, 4829 |
MedlinePlus |
a613026, a699016 |
ChEBI |
72323, 8228 |
ATC code |
A10BH04, A10BG03 |
DrugBank |
DB11827, DB01261 |
KEGG |
DB01132 |
Routes of administration |
By mouth |
Directions
Oseni is available as a tablet in the following strengths:
12.5 mg alogliptin/15 mg pioglitazone, 12.5 mg/30 mg pioglitazone, 12.5 mg alogliptin/45 mg pioglitazone
25 mg alogliptin/15 mg pioglitazone, 25 mg alogliptin/30 mg pioglitazone, 25 mg alogliptin/45 mg pioglitazone
Your initial dose will depend on your current regimen and medical condition(s). The daily oral dose should not be more than alogliptin 25 mg/pioglitazone 45 mg.
Your dose may be adjusted if you have heart failure, kidney problems, or if you take certain medications such as gemfibrozil.
Oseni can be taken with or without food.
Ingredients
The active ingredients in Oseni are alogliptin and pioglitazone.
Contraindications
Discuss your allergies with your doctor. Do not take Oseni if you are allergic to alogliptin, pioglitazone, or any of the other ingredients in Oseni.
Do not take Oseni if you have been diagnosed with NYHA Class III or IV heart failure.
Cautions
WARNING: CONGESTIVE HEART FAILURE
See full prescribing information for complete boxed warning
- Thiazolidinediones, including pioglitazone, cause or
exacerbate congestive heart failure in some patients.
- After initiation of OSENI and after dose increases, monitor
patients carefully for signs and symptoms of heart failure (e.g., excessive, rapid weight gain, dyspnea, and/or edema). If heart failure develops, it should be managed according to current standards of care and discontinuation or dose reduction of pioglitazone in OSENI must be considered.
- OSENI is not recommended in patients with symptomatic heart failure.
- Initiation of OSENI in patients with established New York Heart Association (NYHA) Class III or IV heart failure is contraindicated.
|
- Before you start taking Oseni, tell your doctor:
- About any medications you take, including prescription, over-the-counter, vitamins, and supplements
- About any health conditions you have
- If you are pregnant or plan to become pregnant
- If you are breastfeeding or plan to breastfeed
- Oseni can worsen or cause congestive heart failure. Tell your doctor if you have trouble breathing with activity or when lying down, fatigue, weakness, swelling in the abdomen, legs, ankles, and feet, abnormal heart beat, a cough that won't go away, rapid weight gain, nausea, no appetite, problems concentrating, or chest pain.
- Oseni can cause acute pancreatitis. Seek medical care right away if you develop pain in your abdomen, pain that radiates from your abdomen to your back, tenderness of the abdomen, fever, quickened pulse, nausea, and vomiting.
- Oseni can cause liver problems that can sometimes be fatal.
- Oseni can cause swelling.
- Oseni can increase the risk for fractures in female patients.
- Oseni can increase the risk for bladder cancer. If you have a history of bladder cancer, caution should be used. Do not take Oseni if you have active bladder cancer.
- Low blood sugar can occur when taking Oseni with insulin or other medications that can also lower your blood sugar. Monitor for signs of low blood sugar and treat your low blood sugar as your doctor has instructed.
- Tell your doctor if you experience vision problems while taking Oseni.
Side Effects
The most common side effects of Oseni include common cold, back pain, and upper respiratory tract infection. Contact your doctor right away if you develop troublesome or persistent side effects.
References:
- Oseni Prescribing Information. Deerfield, IL: Takeda Pharmaceuticals America, Inc.; 2013.
- Heart failure. Mayo Clinic. December 10, 2021. Accessed February 4, 2022.
- Pancreatitis. Mayo Clinic. September 24, 2021. Accessed February 4, 2022.
Frequently Asked Questions about Oseni (Alogliptin and Pioglitazone)
What is Oseni and what is it used for?
Oseni is a prescription medication that combines alogliptin and pioglitazone to help control blood sugar levels in adults with type 2 diabetes. It's used alongside diet and exercise.
How does Oseni work?
Alogliptin helps your body produce more insulin, while pioglitazone makes your body's cells more sensitive to insulin. This combination lowers blood sugar.
How is Oseni taken?
Oseni is usually taken once daily as a tablet, with or without food. Your doctor will determine the appropriate dosage.
What are the common side effects of Oseni?
Headache, weight gain, fluid retention, and urinary tract infections are common. More serious side effects can occur, so talk to your doctor about all potential risks.
Who shouldn't take Oseni?
Oseni isn't for everyone. It's not recommended for people with heart failure, liver problems, diabetic ketoacidosis, or a history of bladder cancer.
Can Oseni be taken with other medications?
Tell your doctor about all medications and supplements you take, as some can interact with Oseni.
Does Oseni affect blood sugar monitoring?
Oseni can lower blood sugar, so monitor your levels closely and adjust your medication as needed with your doctor's guidance.
Does Oseni cause weight gain?
Weight gain can be a side effect, especially at higher doses. Discuss this with your doctor and manage your diet and exercise accordingly.
Can I drink alcohol while taking Oseni?
Excessive alcohol consumption can worsen blood sugar control. Talk to your doctor about safe alcohol intake while on Oseni.
What should I do if I miss a dose of Oseni?
Take the missed dose as soon as you remember, but skip it if it's near time for your next dose. Don't double up on doses.
About Dr. Savannah Muncy (Page Author)
Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13594